Currently available therapies in mitochondrial disease

Handb Clin Neurol. 2023:194:189-206. doi: 10.1016/B978-0-12-821751-1.00007-5.

Abstract

Mitochondrial diseases are a heterogeneous group of multisystem disorders caused by impaired mitochondrial function. These disorders occur at any age and involve any tissue, typically affecting organs highly dependent on aerobic metabolism. Diagnosis and management are extremely difficult due to various underlying genetic defects and a wide range of clinical symptoms. Preventive care and active surveillance are strategies to try to reduce morbidity and mortality by timely treatment of organ-specific complications. More specific interventional therapies are in early phases of development and no effective treatment or cure currently exists. A variety of dietary supplements have been utilized based on biological logic. For several reasons, few randomized controlled trials have been completed to assess the efficacy of these supplements. The majority of the literature on supplement efficacy represents case reports, retrospective analyses and open-label studies. We briefly review selected supplements that have some degree of clinical research support. In mitochondrial diseases, potential triggers of metabolic decompensation or medications that are potentially toxic to mitochondrial function should be avoided. We shortly summarize current recommendations on safe medication in mitochondrial diseases. Finally, we focus on the frequent and debilitating symptoms of exercise intolerance and fatigue and their management including physical training strategies.

Keywords: Dietary supplements; Drugs; Exercise intolerance; Exercise training; Fatigue; Management; Medication; Mitochondrial disease; Surveillance; Therapy; Treatment.

Publication types

  • Review

MeSH terms

  • Exercise
  • Fatigue
  • Humans
  • Mitochondria
  • Mitochondrial Diseases*
  • Retrospective Studies